Literature DB >> 8460616

Growth and body composition in children infected with the human immunodeficiency virus-1.

T L Miller1, S J Evans, E J Orav, V Morris, K McIntosh, H S Winter.   

Abstract

Anthropometric data were collected on 89 children born to human immunodeficiency virus (HIV)-infected women (37 who seroreverted and 52 who were HIV-infected). The main outcomes included birth weight, gestational age, weight, height, arm muscle circumference (AMC), and triceps skinfold thickness (TSF). Gestational age and birth weight were not different between the two groups. The earliest anthropometric evaluation on seroreverted children (age 19 mo) when compared with HIV-infected children (age 21 mo) revealed that weight and weight-for-height percentiles were significantly different (51% vs 33% and 66% vs 48%, respectively). Height and TSF percentiles were not different, although AMC percentiles were lower in infected children (64% vs 43%). In follow-up evaluations, the weight differences between infected and control children did not change. We conclude that HIV does not affect birth weight, but postnatal events result in altered weight gain in HIV-infected children. Lean body mass is lower than in an HIV-negative comparison group at early stages of HIV infection.

Entities:  

Mesh:

Year:  1993        PMID: 8460616     DOI: 10.1093/ajcn/57.4.588

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  25 in total

Review 1.  Nutrition and HIV infection in children.

Authors:  E E Mannick; J N Udall; M Kaiser; G Fuchs; R Suskind
Journal:  Indian J Pediatr       Date:  1996 Sep-Oct       Impact factor: 1.967

Review 2.  Wasting disease in African children: the challenges ahead.

Authors:  Geert Tom Heikens; Mark Manary
Journal:  Malawi Med J       Date:  2009-09       Impact factor: 0.875

3.  Predictors of growth and body composition in HIV-infected children beginning or changing antiretroviral therapy.

Authors:  C J Chantry; J S Cervia; M D Hughes; C Alvero; J Hodge; P Borum; J Moye
Journal:  HIV Med       Date:  2010-03-21       Impact factor: 3.180

Review 4.  Impact of antiretroviral therapy on growth, body composition and metabolism in pediatric HIV patients.

Authors:  Roy J Kim; Richard M Rutstein
Journal:  Paediatr Drugs       Date:  2010-06       Impact factor: 3.022

5.  Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study.

Authors:  T L Miller; K A Easley; W Zhang; E J Orav; D M Bier; E Luder; A Ting; W T Shearer; J H Vargas; S E Lipshultz
Journal:  Pediatrics       Date:  2001-12       Impact factor: 7.124

Review 6.  Patterns of postnatal growth in HIV-infected and HIV-exposed children.

Authors:  Sheila Isanaka; Christopher Duggan; Wafaie W Fawzi
Journal:  Nutr Rev       Date:  2009-06       Impact factor: 7.110

7.  Changes in macronutrient intake among HIV-infected children between 1995 and 2004.

Authors:  Tanvi S Sharma; Daniel D Kinnamon; Christopher Duggan; Geoffrey A Weinberg; Lauren Furuta; Lori Bechard; Jeanne Nicchitta; Sherwood L Gorbach; Tracie L Miller
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

8.  Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1.

Authors:  Tracie L Miller; E John Orav; Steven E Lipshultz; Kristopher L Arheart; Christopher Duggan; Geoffrey A Weinberg; Lori Bechard; Lauren Furuta; Jeanne Nicchitta; Sherwood L Gorbach; Abby Shevitz
Journal:  J Pediatr       Date:  2008-06-09       Impact factor: 4.406

9.  Maternal HIV infection, drug use, and growth of uninfected children in their first 3 years.

Authors:  A Ross; G M Raab; J Mok; S Gilkison; B Hamilton; F D Johnstone
Journal:  Arch Dis Child       Date:  1995-12       Impact factor: 3.791

10.  A.S.P.E.N. clinical guidelines: nutrition support of children with human immunodeficiency virus infection.

Authors:  Nasim Sabery; Christopher Duggan
Journal:  JPEN J Parenter Enteral Nutr       Date:  2009 Nov-Dec       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.